Related Experiment Video
Updated: Dec 17, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
The impact of left ventricular diastolic dysfunction for the prognosis in patients with lower extremity arterial
Jen-Kuang Lee1,2,3, Juey-Jen Hwang1, Fu-Tien Chiang1
1Division of Cardiology, Department of Internal Medicine, National Taiwan University College of Medicine and Hospital, Taipei, Taiwan.
Insights
Left ventricular diastolic dysfunction (LVDD) is a significant predictor of mortality and major adverse cardiac events (MACE) in patients with lower extremity arterial disease (LEAD). Early identification of LVDD may improve outcomes for LEAD patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Echocardiography
Background:
- Lower extremity arterial disease (LEAD) and left ventricular diastolic dysfunction (LVDD) share common risk factors.
- The prognostic implications of LVDD in LEAD patients are not fully understood.
Purpose of the Study:
- To investigate the impact of LVDD on clinical outcomes in patients with LEAD.
- To assess the association between LVDD severity and prognosis in LEAD.
Main Methods:
- Classified LVDD using the American Society of Echocardiography guidelines.
- Conducted survival analysis for mortality and major adverse cardiac events (MACE).
- Utilized multivariate Cox regression analysis in 464 LEAD patients and 221 controls.
Main Results:
- Prevalence and severity of LVDD were proportional to LEAD severity (Rutherford class).
- LVDD grade significantly predicted MACE (HR=2.11) and mortality (HR=1.47) in LEAD patients.
- This association remained significant even after endovascular therapy (EVT).
Conclusions:
- The degree of LVDD is a significant predictor of MACE and mortality in LEAD patients.
- Further large-scale studies are needed to confirm the benefit of early LVDD identification in LEAD management.
Aims:
Lower extremity arterial disease (LEAD) and left ventricular diastolic dysfunction (LVDD) share many risk factors, but the characteristics of LVDD and its association with prognosis in patients with LEAD have not been fully examined.
Methods And Results:
We investigated the impact of LVDD on the clinical outcomes in LEAD patients. LVDD was classified according to the newest suggested classification by the American Society of Echocardiography. Survival analysis for mortality (primary endpoint) and major adverse cardiac events (MACE; secondary endpoint) was calculated with all clinical variables and adjusted by multivariate Cox regression. We consecutively enrolled 221 controls and 464 LEAD patients from outpatient clinics and hospitals. The prevalence of LVDD was proportional to the severity of LEAD defined by the Rutherford class. The difference of LVDD severity is significant when compared with the control and LEAD patients or LEAD patients who underwent endovascular therapy (EVT), and it is also proportional to the LEAD severity. The grade of LVDD was a significant factor in predicting MACE and mortality in LEAD patients after multivariate Cox regression analysis [hazard ratio (HR) = 2.11, 95% CI = 1.47-2.83, P = 0.026; HR = 1.47, 95% CI = 1.02-2.02, P = 0.041]. This impact remained significant in LEAD patients who underwent EVT.
Conclusions:
The degree of LVDD may predict MACE and mortality in LEAD patients. Whether early identification of LVDD in LEAD patients is helpful warrants further large-scale prospective randomized studies.
Related Concept Videos
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Aortic Regurgitation III: Medical Management
Mitral Stenosis I: Introduction
Peripheral Artery Disease IV: Nursing Management
Heart Failure II: Pathophysiology
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

